Image

A Study Evaluating Implementation Strategies for the Delivery of APRETUDE for Black cis-and Transgender Women in United States EHE Territories

Evaluating APRETUDE delivery for Black cis- and transgender women in the US.

Recruiting
18 years and older
Female
Phase 4

This study looks at how well a medicine called **Cabotegravir (CAB)** works to prevent HIV in Black cisgender and transgender women in the United States. _Cabotegravir_ is a type of pre-exposure prophylaxis (PrEP), a medicine taken to prevent getting HIV. The study will find out how easy it is to use, how well it works, and what makes it hard or easy for people to use. There are two groups in the study: **Patient Study Participants (PSPs)**, who will take the medicine, and **Staff Study Participants (SSPs)**, who will help give the medicine and check on the patients.

  • The study is for adults 18 years or older who are HIV negative.
  • You cannot join if you're in another study or if you're a cis- or transgender male.
  • Participants must be African American/Black and female at birth or identify as a transgender female.

Participants need to be able to understand and agree to the study rules. They will get CAB PrEP from a provider who thinks it is right for them. This study helps understand how to best offer CAB PrEP to those who need it.

Study details
    HIV Infections

NCT05514509

ViiV Healthcare

13 December 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Race
Ethnicity
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.